Tag: TAK-901

This study highlights the clinical features, treatments, and outcomes from the

This study highlights the clinical features, treatments, and outcomes from the rare myocarditis in adult-onset Still disease (AOSD). 50% of sufferers with myocarditis. Intravenous immunoglobulins, methotrexate, and tumor necrosis factor–blockers had been also prescribed and frequently found effective. Only one 1 patient passed away from cardiogenic surprise. Sufferers with myocarditis-complicated AOSD had been younger and… Continue reading This study highlights the clinical features, treatments, and outcomes from the

Purpose To review the recurrence-free interval (RFI) and basic safety profile

Purpose To review the recurrence-free interval (RFI) and basic safety profile in sufferers with completely resected high-risk early-stage ovarian cancers sufferers treated with intravenous (IV) carboplatin and paclitaxel with or without maintenance low-dose paclitaxel for 24 weeks. wks. Recurrence required radiological or clinical proof new tumor. Results There have been 571 sufferers enrolled onto this… Continue reading Purpose To review the recurrence-free interval (RFI) and basic safety profile